Used as main image by Phynd in search results and profile page

Abhishek A Solanki, MD

Radiation Oncology

Provider Groups

  • Loyola Medicine Physician

  • Loyola Physician Partners

Primary Contact

888-584-7888
Provider Groups
  • Loyola Medicine Physician

  • Loyola Physician Partners

Primary Contact
888-584-7888

Services & Specialties

Areas of Specialization

  • Radiation Oncology

Clinical Interests

Conditions Treated

  • bladder cancer
  • brachytherapy
  • genitourinary cancers
  • high dose rate brachytherapy
  • kidney cancer
  • spaceoar hydrogel
  • testicular cancer

Locations & Contact

Primary Location

Loyola University Medical Center

2160 S First Ave
Maywood , IL 60153

View hours
Tuesday
8:00am - 5:00pm
Monday
8:00am - 5:00pm
Wednesday
8:00am - 5:00pm
Thursday
8:00am - 5:00pm
Friday
8:00am - 5:00pm
Saturday
8:00am - 5:00pm
Sunday
8:00am - 5:00pm
Loyola University Medical Center

About

Academic Title

Associate Professor

Leadership Title

Quality Medical Director, Radiation Oncology

Ages Seen

Adults - Over 65
Adults - 18 to 64

Additional Resources

Education & Certifications

Education

Education:
University of Chicago Pritzker School of Medicine (2009)

Internship:
Maimonides Medical Center (2010)

Residency:
University of Chicago (2014)

Board Certifications

Radiation Oncology, Radiation Oncology, American Board of Radiology Subspecialty (2015)

Provider Groups

Loyola Medicine Physician

Loyola Physician Partners

Provider Ratings

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn More >

4.8 out of 5

(70 ratings)

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

22 Reviews

08/27/2024

Dr.Salonki ensured willingness to continue care until problems are resolved

07/16/2024

The Provider answered my question truly and offered me solutions for my upcoming surgery.

06/25/2024

Dr Solanki was very informative & explained what was necesary to save my life. I rusted him for doing the correct things to help me.

05/21/2024

All the doctors and staff are very very good the nurses are very very personal and very very nice

05/21/2024

easy to talk to and answers all my questions and puts at ease

05/21/2024

Very good

01/25/2024

Pleased with the doctor

01/16/2024

Everybody was nice

12/05/2023

Very knowledgeable

11/30/2023

Helpful information and recommendation

11/28/2023

All good

11/21/2023

Dr. Solanki was very nice and informative

11/21/2023

Intelligent, listener, competent, friendly.

11/09/2023

Dr. Solanski is very compassionate. He always gets equally excited when I have good lab reports.

10/03/2023

Keep up the great work, your level of care is encouraging and the key reason to return.

09/27/2023

Great Doctor

09/14/2023

I’m very satisfied with Loyola

09/08/2023

The Burr Ridge nurses were especially pleasant, professional, and accommodating.

08/13/2023

He always listens to things I say and encourages questions.

08/13/2023

Dr Solanki explains everything in great detail and answers all questions.

08/12/2023

Thank you for everything you guys been doing for me

08/05/2023

So far i like Loyola
Show more

Publications

  • American Radium Society Appropriate Use Criteria for the Workup and Treatment of Local Intraprostatic Recurrence of Prostate Cancer Following Definitive Radiotherapy. Valle, L. F.; Jiang, T.; Rosenbloom, A.; Zaorsky, N. G.; Hwang, C.; Solanki, A.; Dickstein, D.; Mitin, T.; Schroeder, T.; Potters, L.; Lloyd, S.; Showalter, T.; Bagshaw, H. P.; Jeffrey Karnes, R.; Hoffman, K. E.; Nguyen, P. L.; Kishan, A. U.; European urology oncology
  • Systematic review and recommendations for re-irradiation for intraprostatic radiorecurrent prostate cancer after definitive radiation therapy. Saripalli, A. L.; Venkatesulu, B. P.; Nickols, N. G.; Valle, L. F.; Harkenrider, M. M.; Kishan, A. U.; Solanki, A. A.; World journal of urology
  • Challenges and Opportunities in Developing an Oncology Clinical Trial Network in the United States Veterans Affairs Health Care System: The VA STARPORT Experience. Solanki, A. A.; Zheng, K.; Skipworth, A. N.; Robin, L. M.; Leparski, R. F.; Henry, E.; Rettig, M.; Salama, J. K.; Ritter, T.; Jones, J.; Quek, M.; Chang, M.; Block, A. M.; Welsh, J. S.; Kumar, A.; Chao, H. H.; Chen, A. C.; Shapiro, R.; Bitting, R. L.; Kwon, R.; Stross, W.; Puckett, L.; Wong, Y. N.; Nickols, N. G.; Carlson, K.; VA STARPORT Investigators Group; Current oncology (Toronto, Ont.)
  • A Systematic Review of Clinical Trials Comparing Radiation Therapy Versus Radical Prostatectomy in Prostate Cancer. Hekman, L.; Barrett, A.; Ross, D.; Palaganas, E.; Giridhar, P.; Elumalai, T.; V, P.; Block, A. M.; Welsh, J. S.; Harkenrider, M. M.; Saini, S.; Roy, S.; Farooq, A.; Gupta, G.; Hsieh, C. E.; Venkatesulu, B.; Solanki, A. A.; Clinical genitourinary cancer
  • Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712. Rana, Z.; Kamran, S. C.; Shetty, A. C.; Sutera, P.; Song, Y.; Bazyar, S.; Solanki, A. A.; Simko, J. P.; Pollack, A.; McConkey, D.; Kates, M.; Siddiqui, M. M.; Hiken, J.; Earls, J.; Messina, D.; Mouw, K. W.; Miyamoto, D.; Shipley, W. U.; Michaelson, M. D.; Zietman, A.; Coen, J. J.; Dahl, D. M.; Jani, A. B.; Souhami, L.; Chang, B. K.; Lee, R. J.; Pham, H.; Marshall, D. T.; Shen, X.; Pugh, S. L.; Feng, F. Y.; Efstathiou, J. A.; Tran, P. T.; Deek, M. P.; European urology oncology
  • Systemic and Tumor-directed Therapy for Oligometastatic Prostate Cancer: The SOLAR Phase 2 Trial in De Novo Oligometastatic Prostate Cancer. Nickols, N. G.; Tsai, S.; Kane, N.; Tran, S.; Ghayouri, L.; Diaz-Perez, S.; Thein, M.; Anderson-Berman, N.; Eason, J.; Kishan, A. U.; Steinberg, M. L.; Reiter, R. E.; Lee, S. P.; Gin, G. E.; Kwon, R.; Chang, M. G.; Chao, H. H.; Solanki, A. A.; Sexton, R.; Lewis, M.; Lorentz, W.; Cheung, M. K.; Gage, D. L.; Duriseti, S.; Valle, L.; Berenji, G.; Aronson, W. J.; Garraway, I. P.; Rettig, M. B.; European urology
  • Meta-Analysis of Candidate Surrogate End Points in Advanced Prostate Cancer. Gharzai, L. A.; Jiang, R.; Jaworski, E. M.; Morales Rivera, K.; Dess, R. T.; Jackson, W. C.; Hartman, H. E.; Mehra, R.; Kishan, A. U.; Solanki, A. A.; Schaeffer, E. M.; Feng, F. Y.; Zaorsky, N. G.; Berlin, A.; Ponsky, L.; Shoag, J.; Sun, Y.; Schipper, M. J.; Garcia, J.; Spratt, D. E.; NEJM evidence
  • Monitoring Intrafraction Motion of the Prostate During Radiation Therapy: Suggested Practice Points From a Focused Review. Shimomura, A.; Wu, T.; Rusu, I.; Kishan, A. U.; Tree, A. C.; Solanki, A. A.; Liauw, S. L.; Practical radiation oncology
  • F-SHARP: a Phase I/II trial of focal salvage high-dose-rate brachytherapy for Radiorecurrent prostate cancer. Solanki, A. A.; Yoo, R. K.; Adams, W.; Davicioni, E.; Mysz, M. L.; Shea, S.; Gupta, G. N.; Showalter, T.; Garant, A.; Hentz, C.; Farooq, A.; Baldea, K.; Small, W.; Harkenrider, M. M.; BJU international
  • Prostate segmentation accuracy using synthetic MRI for high-dose-rate prostate brachytherapy treatment planning. Kang, H.; Podgorsak, A. R.; Venkatesulu, B. P.; Saripalli, A. L.; Chou, B.; Solanki, A. A.; Harkenrider, M.; Shea, S.; Roeske, J. C.; Abuhamad, M.; Physics in medicine and biology
  • Identification of Key Elements in Prostate Cancer for Ontology Building via a Multidisciplinary Consensus Agreement. Moreno, A.; Solanki, A. A.; Xu, T.; Lin, R.; Palta, J.; Daugherty, E.; Hong, D.; Hong, J.; Kamran, S. C.; Katsoulakis, E.; Brock, K.; Feng, M.; Fuller, C.; Mayo, C.; BDSC Prostate Cancer Consortium; Cancers
  • Dosimetric and workflow impact of synthetic-MRI use in prostate high-dose-rate brachytherapy. Podgorsak, A. R.; Venkatesulu, B. P.; Abuhamad, M.; Harkenrider, M. M.; Solanki, A. A.; Roeske, J. C.; Kang, H.; Brachytherapy
  • MGMT Methylated High Grade Glioma with Distant Recurrence and Stable Original Tumor Site: Case Series. Lee, J.; Lukas, R. V.; Jusue-Torres, I.; Germanwala, A. V.; Borys, E.; Solanki, A. A.; Mallik, A. K.; Barton, K.; Thakkar, J. P.; Annals of hematology & oncology
  • Multi-institutional Development and Validation of Contouring Guidelines for Para-aortic Elective Nodal Irradiation in Prostate Cancer Based on Patterns of Involvement on Targeted Molecular Imaging Positron Emission Tomography/Computed Tomography. Saripalli, A. L.; Lee, B.; Adams, W.; Bhandare, N.; Venkatesulu, B. P.; Yoo, R. K.; Price, J.; Harmon, G. A.; Block, A. M.; Friedman, N.; Harkenrider, M. M.; Major, E. J.; Small, W.; Wagner, R. H.; Welsh, J. S.; Solanki, A. A.; International journal of radiation oncology, biology, physics
  • Looking Backward and Forward: Learning From and Updating the ASTRO Safety White Papers 10 Years Later. Solanki, A. A.; Burmeister, J.; Mak, R. H.; Moran, J. M.; Practical radiation oncology
  • Editorial Commentary. Koehne, E. L.; Solanki, A. A.; Gorbonos, A.; Urology practice
  • Consensus Quality Measures and Dose Constraints for Lung Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and ASTRO Expert Panel. Puckett, L. L.; Titi, M.; Kujundzic, K.; Dawes, S. L.; Gore, E. M.; Katsoulakis, E.; Park, J. H.; Solanki, A. A.; Kapoor, R.; Kelly, M.; Palta, J.; Chetty, I. J.; Jabbour, S. K.; Liao, Z.; Movsas, B.; Thomas, C. R.; Timmerman, R. D.; Werner-Wasik, M.; Kudner, R.; Wilson, E.; Simone, C. B.; Practical radiation oncology
  • Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international Delphi consensus study. Corkum, M. T.; Buyyounouski, M. K.; Chang, A. J.; Chung, H. T.; Chung, P.; Cox, B. W.; Crook, J. M.; Davis, B. J.; Frank, S. J.; Henriquez, I.; Horwitz, E. M.; Hoskin, P.; Hsu, I. C.; Keyes, M.; King, M. T.; Kollmeier, M. A.; Krauss, D. J.; Kukielka, A. M.; Morton, G.; Orio, P. F.; Pieters, B. R.; Potters, L.; Rossi, P. J.; Showalter, T. N.; Solanki, A. A.; Song, D.; Vanneste, B.; Vigneault, E.; Wojcieszek, P. A.; Zelefsky, M. J.; Kamrava, M.; Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • A Systematic Review and Meta-analysis of the Impact of Radiation-Related Lymphopenia on Outcomes in High-Grade Gliomas. Mallick, S.; V R, A.; Giridhar, P.; Upadhyay, R.; Kim, B. K.; Sharma, A.; Elghazawy, H.; Elumalai, T.; Solipuram, V.; Hsieh, C. E.; Hentz, C.; Solanki, A. A.; Li, J.; Chan, D. P.; Ness, E.; Venkatesulu, B. P.; Grosshans, D. R.; South Asian journal of cancer
  • Bladder only versus bladder plus pelvic lymph node chemoradiation for muscle-invasive bladder cancer. Patel, S. A.; Liu, Y.; Solanki, A. A.; Baumann, B. C.; Efstathiou, J. A.; Jani, A. B.; Chang, A. J.; Fischer-Valuck, B.; Royce, T. J.; Urologic oncology
  • Consensus Quality Measures and Dose Constraints for Prostate Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel. Solanki, A. A.; Puckett, L. L.; Kujundzic, K.; Katsoulakis, E.; Park, J.; Kapoor, R.; Hagan, M.; Kelly, M.; Palta, J.; Ballas, L. K.; DeMarco, J.; Hoffman, K. E.; Lawton, C. A. F.; Michalski, J.; Potters, L.; Zelefsky, M.; Kudner, R.; Dawes, S.; Wilson, E.; Sandler, H.; Practical radiation oncology
  • Multidisciplinary Management and Radiotherapy Recommendations for Clinically and Pathologically Node-positive Bladder Cancer. Venkatesulu, B.; Liauw, S. L.; Joshi, M.; Baumann, B. C.; Yoo, R.; Roupret, M.; Choudhury, A.; Efstathiou, J. A.; Murthy, V.; Sargos, P.; Solanki, A. A.; Seminars in radiation oncology
  • Consensus Statement Supporting the Presence of Onsite Radiation Oncology Departments at VHA Medical Centers. Gutt, R.; Shapiro, R. H.; Lee, S. P.; Faricy-Anderson, K.; Hoffman-Hogg, L.; Solanki, A. A.; Moses, E.; Dawson, G. A.; Kelly, M. D.; Federal practitioner : for the health care professionals of the VA, DoD, and PHS
  • Lymphocyte sparing normal tissue effects in the clinic (LymphoTEC): A systematic review of dose constraint considerations to mitigate radiation-related lymphopenia in the era of immunotherapy. Venkatesulu, B.; Giridhar, P.; Pujari, L.; Chou, B.; Lee, J. H.; Block, A. M.; Upadhyay, R.; Welsh, J. S.; Harkenrider, M. M.; Krishnan, S.; Verma, V.; En Hsieh, C.; Pradhan, S.; Small, W.; Solanki, A. A.; Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • Consensus Quality Measures and Dose Constraints for Breast Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel. Puckett, L. L.; Kodali, D.; Solanki, A. A.; Park, J. H.; Katsoulakis, E.; Kudner, R.; Kapoor, R.; Kujundzic, K.; Chapman, C. H.; Hagan, M.; Kelly, M.; Palta, J.; Bazan, J. G.; Dragun, A.; Fisher, C.; Haffty, B.; Nichols, E.; Shah, C.; Salehpour, M.; Dawes, S.; Wilson, E.; Buchholz, T. A.; Practical radiation oncology
  • Consensus Quality Measures and Dose Constraints for Rectal Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert Panel. Park, J.; Venkatesulu, B. P.; Kujundzic, K.; Katsoulakis, E.; Solanki, A. A.; Puckett, L. L.; Kapoor, R.; Chapman, C. H.; Hagan, M.; Kelly, M. D.; Palta, J.; Ashman, J. B.; Jacqmin, D.; Kachnic, L. A.; Minsky, B. D.; Olsen, J.; Raldow, A. C.; Wo, J. Y.; Dawes, S.; Wilson, E.; Kudner, R.; Das, P.; Practical radiation oncology
  • Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Quality Measures Initiative. Park, J.; Puckett, L. L.; Katsoulakis, E.; Venkatesulu, B. P.; Kujundzic, K.; Solanki, A. A.; Movsas, B.; Simone, C. B.; Sandler, H.; Lawton, C. A.; Das, P.; Wo, J. Y.; Buchholz, T. A.; Fisher, C. M.; Harrison, L. B.; Sher, D. J.; Kapoor, R.; Chapman, C. H.; Dawes, S.; Kudner, R.; Wilson, E.; Hagan, M.; Palta, J.; Kelly, M. D.; Practical radiation oncology
  • Paving the Road to the Future of Chemoradiotherapy in Muscle-invasive Bladder Cancer: 10-year Follow-up of BC2001. Solanki, A. A.; Kates, M. R.; Tran, P. T.; European urology
  • In Reply to Guler and Onal. Harmon, G.; Solanki, A. A.; International journal of radiation oncology, biology, physics
  • An Expert Review on the Combination of Relugolix With Definitive Radiation Therapy for Prostate Cancer. Roy, S.; Zaorsky, N. G.; Bagshaw, H. P.; Berlin, A.; Tree, A.; Turner, S.; Koontz, B.; Nguyen, P.; Chen, R.; Dess, R. T.; Jackson, W. C.; Kishan, A. U.; Stish, B.; Nagar, H.; Posadas, E.; Tran, P. T.; Solanki, A.; Shore, N. D.; Guo, G.; Ponsky, L.; Shoag, J. E.; Morgans, A. K.; Garcia, J. A.; Showalter, T. N.; Feng, F. Y.; Spratt, D. E.; International journal of radiation oncology, biology, physics
  • Facilitating the Transition to Independent Radiation Oncology Practice Through a Resident-Led, Veterans Affairs Teaching Hospital Service. Price, J. G.; Moravan, M. J.; Boyer, M. J.; Palta, M.; Stephens, S. J.; Eyler, C. E.; Siglin, J. J.; Solanki, A. A.; Patel, P. R.; Lee, W. R.; Salama, J. K.; Practical radiation oncology
  • Health-Related Quality of Life and Toxicity After Definitive High-Dose-Rate Brachytherapy Among Veterans With Prostate Cancer. Harris, A. A.; Yasuda, M.; Wu, M. S.; Deirmenjian, J. M.; Farooq, A.; Baldea, K. G.; Flanigan, R.; Harkenrider, M. M.; Welsh, J. S.; Solanki, A. A.; Federal practitioner : for the health care professionals of the VA, DoD, and PHS
  • ACR-ABS-ASTRO practice parameter for the performance of radionuclide-based high-dose-rate brachytherapy. Harkenrider, M. M.; Albuquerque, K.; Brown, D.; Kamrava, M.; King, M.; Mourtada, F.; Orio, P.; Patel, R.; Price, M.; Rassiah, P.; Solanki, A. A.; Small, W.; Schechter, N. R.; Brachytherapy
  • Fully automated planning and delivery of hippocampal-sparing whole brain irradiation. Rusu, I.; Roeske, J.; Solanki, A.; Kang, H.; Medical dosimetry : official journal of the American Association of Medical Dosimetrists
  • Positivity Rate of [18F]Fluciclovine PET/CT in Patients with Suspected Prostate Cancer Recurrence at PSA Levels Below 1 ng/mL. Bulbul, J. E.; Grybowski, D.; Lovrec, P.; Solanki, A. A.; Gabriel, M. S.; Wagner, R. H.; Savir-Baruch, B.; Molecular imaging and biology
  • Validating Modern NRG Oncology Pelvic Nodal and Groupe Francophone de Radiothérapie Urologique Prostate Bed Contouring Guidelines for Post-Prostatectomy Salvage Radiation: A Secondary Analysis of the LOCATE Trial. Harmon, G.; Chan, D.; Lee, B.; Miller, C.; Gorbonos, A.; Gupta, G.; Quek, M.; Woods, M.; Savir-Baruch, B.; Harkenrider, M. M.; Solanki, A. A.; International journal of radiation oncology, biology, physics
  • ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer: 2021 Update. Expert Panel on Urological Imaging; Allen, B. C.; Oto, A.; Akin, O.; Alexander, L. F.; Froemming, A. T.; Fulgham, P. F.; Halpern, D. J.; Gettle, L. M.; Maranchie, J. K.; Patel, B. N.; Patlas, M. N.; Schieda, N.; Solanki, A.; Turkbey, I. B.; Venkatesan, A. M.; Yoo, D. C.; Lockhart, M. E.; Journal of the American College of Radiology : JACR
  • Will the Use of Biomarkers Improve Bladder Cancer Radiotherapy Delivery? Solanki, A. A.; Venkatesulu, B. P.; Efstathiou, J. A.; Clinical oncology (Royal College of Radiologists (Great Britain))
  • Three discipline collaborative radiation therapy (3DCRT) special debate: Peer review in radiation oncology is more effective today than 20 years ago. Ahmad, A.; Santanam, L.; Solanki, A. A.; Padilla, L.; Vlashi, E.; Guerrieri, P.; Dominello, M. M.; Burmeister, J.; Joiner, M. C.; Journal of applied clinical medical physics
  • Computed tomography versus magnetic resonance imaging in high-dose-rate prostate brachytherapy planning: The impact on patient-reported health-related quality of life. Harris, A. A.; Wu, M.; Deirmenjian, J. M.; Shea, S. M.; Kang, H.; Patel, R.; Fielder, D.; Mysz, M. L.; Harkenrider, M. M.; Solanki, A. A.; Brachytherapy
  • Safety practices and opportunities for improvement in brachytherapy: A patient safety practices survey of the American Brachytherapy Society membership. Sanders, J. C.; Showalter, T. N.; Ouhib, Z.; Thomadsen, B. R.; Jacob, D.; Agarwal, M.; Cohen, G. N.; Giles, M.; Palaniswammy, G.; Solanki, A. A.; Taunk, N. K.; Members of the ABS Quality and Safety Committee; Brachytherapy
  • Patient and physician reported toxicity with two-fraction definitive high-dose-rate prostate brachytherapy: the impact of implant interval. Harris, A. A.; Korpics, M.; Sherwani, Z.; Farooq, A.; Baldea, K. G.; Flanigan, R.; Harkenrider, M. M.; Solanki, A. A.; Journal of contemporary brachytherapy
  • 18F-Fluciclovine Positron Emission Tomography in Men With Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy and Planning to Undergo Salvage Radiation Therapy: Results from LOCATE. Solanki, A. A.; Savir-Baruch, B.; Liauw, S. L.; Michalski, J.; Tward, J. D.; Vapiwala, N.; Teoh, E. J.; LOCATE study group; Practical radiation oncology
  • The perils of using registry data to compare the survival and cost of radical cystectomy and trimodality therapy in bladder cancer. Solanki, A. A.; Liauw, S. L.; Translational andrology and urology
  • EDITORIAL COMMENT. Solanki, A. A.; Efstathiou, J. A.; Urology
  • The Impact of Transitioning to Prospective Contouring and Planning Rounds as Peer Review. Surucu, M.; Bajaj, A.; Roeske, J. C.; Block, A. M.; Price, J.; Small, W.; Solanki, A. A.; Advances in radiation oncology
  • Fluorine-18-Labeled Fluciclovine PET/CT in Clinical Practice: Factors Affecting the Rate of Detection of Recurrent Prostate Cancer. Savir-Baruch, B.; Lovrec, P.; Solanki, A. A.; Adams, W. H.; Yonover, P. M.; Gupta, G.; Schuster, D. M.; AJR. American journal of roentgenology
  • Combining Immunotherapy with Radiotherapy for the Treatment of Genitourinary Malignancies. Solanki, A. A.; Bossi, A.; Efstathiou, J. A.; Lock, D.; Mondini, M.; Ramapriyan, R.; Welsh, J.; Kang, J.; European urology oncology
  • NRG brain tumor specialists consensus guidelines for glioblastoma contouring. Kruser, T. J.; Bosch, W. R.; Badiyan, S. N.; Bovi, J. A.; Ghia, A. J.; Kim, M. M.; Solanki, A. A.; Sachdev, S.; Tsien, C.; Wang, T. J. C.; Mehta, M. P.; McMullen, K. P.; Journal of neuro-oncology
  • Transitioning From a Low-Dose-Rate to a High-Dose-Rate Prostate Brachytherapy Program: Comparing Initial Dosimetry and Improving Workflow Efficiency Through Targeted Interventions. Solanki, A. A.; Mysz, M. L.; Patel, R.; Surucu, M.; Kang, H.; Plypoo, A.; Bajaj, A.; Korpics, M.; Martin, B.; Hentz, C.; Gupta, G.; Farooq, A.; Baldea, K. G.; Pawlowski, J.; Roeske, J.; Flanigan, R.; Small, W.; Harkenrider, M. M.; Advances in radiation oncology
  • Oligometastatic Disease State Is Associated with Improved Local Control in Patients Undergoing Three or Five Fraction Spine Stereotactic Body Radiotherapy. Silva, S. R.; Gliniewicz, A.; Martin, B.; Prabhu, V. C.; Germanwala, A. V.; Melian, E.; Jones, G. A.; Solanki, A. A.; World neurosurgery
  • Optimizing the Role of Surgery and Radiation Therapy in Urethral Cancer Based on Histology and Disease Extent. Son, C. H.; Liauw, S. L.; Hasan, Y.; Solanki, A. A.; International journal of radiation oncology, biology, physics
  • Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017. Okunieff, P.; Casey-Sawicki, K.; Lockney, N. A.; Hoppe, B. S.; Enderling, H.; Pinnix, C.; Welsh, J.; Krishnan, S.; Yothers, G.; Brown, M.; Knox, S.; Bristow, R.; Spellman, P.; Mitin, T.; Nabavizadeh, N.; Jaboin, J.; Manning, H. C.; Feng, F.; Galbraith, S.; Solanki, A. A.; Harkenrider, M. M.; Tuli, R.; Decker, R. H.; Finkelstein, S. E.; Hsu, C. C.; Ha, C. S.; Jagsi, R.; Shumway, D.; Daly, M.; Wang, T. J. C.; Fitzgerald, T. J.; Laurie, F.; Marshall, D. T.; Raben, D.; Constine, L.; Thomas, C. R.; Kachnic, L. A.; Clinical cancer research : an official journal of the American Association for Cancer Research
  • The Impact of Academic Facility Type and Case Volume on Survival in Patients Undergoing Curative Radiation Therapy for Muscle-Invasive Bladder Cancer. Bajaj, A.; Martin, B.; Bhasin, R.; Hentz, C.; Block, A. M.; Harkenrider, M. M.; Solanki, A. A.; International journal of radiation oncology, biology, physics
  • Improving the Accessibility of Patient Care Through Integration of the Hospital and Radiation Oncology Electronic Health Records. Solanki, A. A.; Surucu, M.; Bajaj, A.; Kaczmarz, B.; Martin, B.; Price, J.; Perino, C.; McCoo, T.; Payonk, G.; Roeske, J. C.; Small, W.; JCO clinical cancer informatics
  • Cranial Base Meningiomas. Prabhu, V. C.; Melian, E.; Germanwala, A. V.; Solanki, A. A.; Borys, E.; Barton, K.; Anderson, D. E.; World neurosurgery
  • Bladder-Preserving Therapy Patterns of Care: A Survey of US Radiation Oncologists. Solanki, A. A.; Martin, B.; Korpics, M.; Small, C.; Harkenrider, M. M.; Mitin, T.; International journal of radiation oncology, biology, physics
  • Concurrent chemotherapy is associated with improved survival in elderly patients with bladder cancer undergoing radiotherapy. Korpics, M. C.; Block, A. M.; Martin, B.; Hentz, C.; Gaynor, E. R.; Henry, E.; Harkenrider, M. M.; Solanki, A. A.; Cancer
  • Adjuvant Radiotherapy Use by US Radiation Oncologists After Radical Cystectomy for Muscle-invasive Bladder Cancer. Solanki, A. A.; Martin, B.; Korpics, M.; Small, C.; Harkenrider, M. M.; Mitin, T.; Clinical oncology (Royal College of Radiologists (Great Britain))
  • Adjuvant Radiotherapy Versus Wait-and-See Strategy for Pathologic T3 or Margin-Positive Prostate Cancer: A Meta-Analysis. Shaikh, M. P.; Alite, F.; Wu, M. J.; Solanki, A. A.; Harkenrider, M. M.; American journal of clinical oncology
  • Observer Evaluation of a Metal Artifact Reduction Algorithm Applied to Head and Neck Cone Beam Computed Tomographic Images. Korpics, M.; Surucu, M.; Mescioglu, I.; Alite, F.; Block, A. M.; Choi, M.; Emami, B.; Harkenrider, M. M.; Solanki, A. A.; Roeske, J. C.; International journal of radiation oncology, biology, physics